Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CI NYSE:CNC NYSE:HUM NYSE:MOH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICigna Group$288.01+1.4%$274.29$239.51▼$338.89$75.14B0.31.63 million shs1.66 million shsCNCCentene$55.97+1.8%$39.59$25.08▼$64.15$27.15B1.066.99 million shs5.30 million shsHUMHumana$274.58+11.1%$192.18$163.11▼$315.35$29.67B0.681.72 million shs3.15 million shsMOHMolina Healthcare$186.07-3.0%$152.32$121.06▼$333.00$10.00B0.851.37 million shs1.54 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICigna Group0.00%-2.35%+2.25%-2.92%-15.18%CNCCentene0.00%+1.97%+47.30%+42.65%-12.41%HUMHumana0.00%+4.40%+24.61%+27.53%-2.31%MOHMolina Healthcare0.00%-1.68%+29.88%+45.33%-41.40%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCICigna Group$288.01+1.4%$274.29$239.51▼$338.89$75.14B0.31.63 million shs1.66 million shsCNCCentene$55.97+1.8%$39.59$25.08▼$64.15$27.15B1.066.99 million shs5.30 million shsHUMHumana$274.58+11.1%$192.18$163.11▼$315.35$29.67B0.681.72 million shs3.15 million shsMOHMolina Healthcare$186.07-3.0%$152.32$121.06▼$333.00$10.00B0.851.37 million shs1.54 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCICigna Group0.00%-2.35%+2.25%-2.92%-15.18%CNCCentene0.00%+1.97%+47.30%+42.65%-12.41%HUMHumana0.00%+4.40%+24.61%+27.53%-2.31%MOHMolina Healthcare0.00%-1.68%+29.88%+45.33%-41.40%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCICigna Group 2.86Moderate Buy$338.3517.48% UpsideCNCCentene 2.32Hold$53.82-3.84% DownsideHUMHumana 2.12Hold$247.61-9.82% DownsideMOHMolina Healthcare 2.06Hold$169.60-8.85% DownsideCurrent Analyst Ratings BreakdownLatest HUM, CNC, CI, and MOH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026CNCCentene Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/5/2026CICigna Group Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$358.00 ➝ $371.005/5/2026CNCCentene JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$41.00 ➝ $52.005/5/2026CNCCentene Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$48.00 ➝ $68.005/4/2026CNCCentene TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$38.00 ➝ $47.005/4/2026CICigna Group GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$334.00 ➝ $338.005/4/2026CICigna Group The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$335.00 ➝ $340.005/1/2026HUMHumana TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$173.00 ➝ $211.005/1/2026CICigna Group Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$340.005/1/2026CICigna Group Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$325.00 ➝ $340.005/1/2026CICigna Group Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$337.00(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCICigna Group$274.90B0.28$41.50 per share6.94$160.44 per share1.80CNCCentene$194.78B0.14$4.77 per share11.73$43.54 per share1.29HUMHumana$129.66B0.25$26.74 per share10.27$155.30 per share1.77MOHMolina Healthcare$45.43B0.21$13.94 per share13.35$78.31 per share2.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCICigna Group$5.96B$23.5912.218.590.992.26%19.75%5.30%N/ACNCCentene-$6.67B-$13.14N/A12.781.06-3.25%5.57%1.54%7/28/2026 (Estimated)HUMHumana$1.19B$9.3529.3718.722.280.82%10.45%3.75%N/AMOHMolina Healthcare$472M$3.3855.0521.79N/A0.42%8.76%2.32%7/22/2026 (Estimated)Latest HUM, CNC, CI, and MOH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2026Q1 2026CICigna Group$7.60$7.79+$0.19$6.26$66.29 billion$68.52 billion4/29/2026Q1 2026HUMHumana$9.97$10.31+$0.34$9.83$39.37 billion$39.65 billion4/28/2026Q1 2026CNCCentene$2.23$3.37+$1.14$3.11$47.53 billion$49.94 billion4/22/2026Q1 2026MOHMolina Healthcare$1.57$2.35+$0.78$0.27$10.91 billion$10.80 billion2/11/2026Q4 2025HUMHumana-$4.01-$3.96+$0.05-$6.61$32.08 billion$32.64 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCICigna Group$6.242.17%+172.77%26.45%5 YearsCNCCenteneN/AN/AN/AN/AN/AHUMHumana$3.541.29%+7.20%37.86%N/AMOHMolina HealthcareN/AN/AN/AN/AN/ALatest HUM, CNC, CI, and MOH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/15/2026HUMHumanaquarterly$0.88501.79%6/26/20266/26/20267/31/20264/22/2026CICigna Groupquarterly$1.562.27%6/4/20266/4/20266/18/20262/19/2026HUMHumanaquarterly$0.88502.09%3/27/20263/27/20264/24/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCICigna Group0.690.730.73CNCCentene0.761.121.12HUMHumana0.661.771.77MOHMolina Healthcare0.971.631.63Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCICigna Group86.99%CNCCentene93.63%HUMHumana92.38%MOHMolina Healthcare98.50%Insider OwnershipCompanyInsider OwnershipCICigna Group0.60%CNCCentene0.37%HUMHumana0.20%MOHMolina Healthcare1.44%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCICigna Group67,700264.53 million262.95 millionOptionableCNCCentene61,100493.80 million491.97 millionOptionableHUMHumana67,060120.06 million119.82 millionOptionableMOHMolina Healthcare19,00052.10 million51.35 millionOptionableHUM, CNC, CI, and MOH HeadlinesRecent News About These CompaniesSwedbank AB Acquires 16,398 Shares of Molina Healthcare, Inc $MOH1 hour ago | marketbeat.comUBS Group AG Cuts Holdings in Molina Healthcare, Inc $MOH1 hour ago | marketbeat.comInvestment Management Associates Inc. ADV Increases Stake in Molina Healthcare, Inc $MOH1 hour ago | marketbeat.comMolina Healthcare (NYSE:MOH) Releases FY 2029 Earnings GuidanceMay 8 at 2:03 PM | marketbeat.comMolina forecasts fivefold jump in 2029 profit if medical costs remain steadyMay 8 at 1:38 PM | msn.comK.J. Harrison & Partners Inc Buys Shares of 6,000 Molina Healthcare, Inc $MOHMay 8 at 6:23 AM | marketbeat.comDanske Bank A S Cuts Stock Position in Molina Healthcare, Inc $MOHMay 6 at 4:05 AM | marketbeat.comPictet Asset Management Holding SA Sells 22,407 Shares of Molina Healthcare, Inc $MOHMay 5, 2026 | marketbeat.comVanguard Stake In Molina Healthcare Highlights Valuation Gap And Profit RisksMay 3, 2026 | finance.yahoo.comVanguard Group Inc. Sells 353,209 Shares of Molina Healthcare, Inc $MOHMay 2, 2026 | marketbeat.comMolina Healthcare (NYSE:MOH) Stock Rating Upgraded by Wall Street ZenMay 2, 2026 | americanbankingnews.comMolina Healthcare (NYSE:MOH) Upgraded at Wall Street ZenMay 2, 2026 | marketbeat.comMolina Healthcare, Inc $MOH Stock Position Reduced by Universal Beteiligungs und Servicegesellschaft mbHMay 1, 2026 | marketbeat.comCwm LLC Has $611,000 Stock Holdings in Molina Healthcare, Inc $MOHMay 1, 2026 | marketbeat.comMolina Healthcare, Inc $MOH Shares Acquired by Wealthfront Advisers LLCApril 30, 2026 | marketbeat.comMolina wins double upgrade at BofA on Medicaid tailwindsApril 29, 2026 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH) and Boston Scientific (BSX)April 29, 2026 | theglobeandmail.comMolina Healthcare (NYSE:MOH) Rating Increased to Buy at Bank of AmericaApril 29, 2026 | marketbeat.com5 revealing analyst questions from Molina Healthcare’s Q1 earnings callApril 29, 2026 | msn.comMolina Healthcare (MOH) price target increased by 11.11% to 166.42April 29, 2026 | msn.comMolina Healthcare (NYSE:MOH) Trading Up 5.8% After Analyst UpgradeApril 28, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Stocks Positioned to Win the AI Data Center BuildoutBy Bridget Bennett | April 20, 2026The Nasdaq's Historic Rally Doesn't Mean the Risk Is GoneBy Bridget Bennett | April 19, 2026AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?By Thomas Hughes | April 29, 2026This 4/20, Wall Street Is Betting on More Than MarijuanaBy Jeffrey Neal Johnson | April 20, 2026Microsoft’s Copilot Problem Isn’t What You ThinkBy Chris Markoch | April 12, 2026HUM, CNC, CI, and MOH Company DescriptionsCigna Group NYSE:CI$288.01 +3.97 (+1.40%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$284.00 -4.01 (-1.39%) As of 05/8/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.Centene NYSE:CNC$55.97 +0.99 (+1.80%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$55.55 -0.42 (-0.75%) As of 05/8/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Humana NYSE:HUM$274.58 +27.46 (+11.11%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$271.06 -3.51 (-1.28%) As of 05/8/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Molina Healthcare NYSE:MOH$186.07 -5.78 (-3.01%) Closing price 05/8/2026 03:59 PM EasternExtended Trading$185.27 -0.80 (-0.43%) As of 05/8/2026 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
